当前位置:首页 - 行情中心 - 通策医疗(600763) - 财务分析

通策医疗

(600763)

  

流通市值:193.90亿  总市值:193.90亿
流通股本:4.47亿   总股本:4.47亿

通策医疗(600763)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润6.16亿元,每股收益1.15元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益470278.74万元,未分配利润395976.27万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产627889.88万元,负债157611.15万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入2,290,207,568.441,448,440,275.71744,611,704.472,873,776,923.07
营业总成本1,651,816,530.611,060,903,412.94516,786,428.412,228,564,644.29
其他经营收益
营业利润686,914,819.32421,194,494.81240,070,432.62698,632,246.94
利润总额684,241,323.4419,921,531.84239,895,201.95694,009,052.6
净利润616,407,609.55380,301,933.78216,103,399.66572,131,489.43
每股收益
其他综合收益4,635,380.153,251,806.450.05-109,339,073.44
综合收益总额621,042,989.7383,553,740.23216,103,399.71462,792,415.99
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计905,438,308.14793,825,115.67935,692,569.16917,637,847.64
非流动资产:
非流动资产合计5,373,460,526.995,368,313,667.725,327,679,518.155,310,299,493.73
资产总计6,278,898,835.136,162,138,783.396,263,372,087.316,227,937,341.37
流动负债:
流动负债合计559,024,207.75620,518,778.06582,937,011.57593,145,731.96
非流动负债:
非流动负债合计1,017,087,252.421,074,453,830.631,106,342,703.881,275,730,436.42
负债合计1,576,111,460.171,694,972,608.691,689,279,715.451,868,876,168.38
所有者权益(或股东权益):
归属于母公司股东权益合计4,343,706,814.814,150,453,776.344,209,627,272.664,027,769,797.34
股东权益合计4,702,787,374.964,467,166,174.74,574,092,371.854,359,061,172.99
负债和股东权益合计6,278,898,835.136,162,138,783.396,263,372,087.36,227,937,341.37
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计2,309,197,889.721,456,983,306.4677,575,609.672,885,252,489.25
经营活动现金流出小计1,627,578,446.451,101,173,599.67529,882,176.052,121,837,510.93
经营活动产生的现金流量净额681,619,443.27355,809,706.73147,693,433.62763,414,978.32
投资活动产生的现金流量:
投资活动现金流入小计13,091,162.649,091,622.785,273,912.51163,330,054.34
投资活动现金流出小计324,328,442.27197,559,876.3469,481,305.03488,301,761.45
投资活动产生的现金流量净额-311,237,279.63-188,468,253.56-64,207,392.52-324,971,707.11
筹资活动产生的现金流量:
筹资活动现金流入小计67,639,567.653,084,567.61,530,156.1690,130,753.77
筹资活动现金流出小计481,156,664.1359,404,885.49108,183,572.96502,819,417.93
筹资活动产生的现金流量净额-413,517,096.5-306,320,317.89-106,653,416.8-412,688,664.16
汇率变动对现金及现金等价物的影响-0.080.080.050.11
现金及现金等价物净增加额-43,134,932.94-138,978,864.64-23,167,375.6525,754,607.16
期末现金及现金等价物余额576,723,746.64480,871,363.96596,682,852.95619,850,228.6
补充资料:
现金及现金等价物的净增加额--138,978,864.64-25,754,607.16
最新报告期:2025-10-31
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
中金公司张琎,朱言音1.231.30--2025-10-31
华泰证券代雯,高鹏,杨昌源1.181.261.352025-10-27
中信建投吴严,王在存,贺菊颖1.181.281.382025-10-13
开源证券阮帅,余汝意1.251.361.572025-08-28
中金公司张琎,朱言音1.231.30--2025-08-26
TOP↑